Related Experiment Video
Updated: Aug 26, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Potential Molecular Mechanism of Upregulated Aryl Hydrocarbon Receptor Nuclear Translocator 2 in Nasopharyngeal
Si-Wei Huang1, Gang Chen1, Jian-Di Li1
1Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region 530031, China.
Background:
Currently, the benefits of nasopharyngeal carcinoma (NPC) therapy are limited, and it is necessary to further explore possible therapeutic targets. Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) has been extensively studied in other cancer species, but little has been explored in NPC. The aim of this study was to verify the expression level of ARNT2 and its underlying mechanism in NPC.
Methods:
Datasets containing ARNT2 mRNA expression levels were retrieved and collected from various databases to explore the expression status of ARNT2 in NPC. ARNT2-related coexpressed genes, differential expressed genes, and target genes were obtained for functional enrichment analysis. The potential target gene of ARNT2 and their regulatory relationship were studied through ChIP-seq data. CIBERSORTx was used to assess the immune infiltration of NPC, and the association with ARNT2 expression was calculated through correlation analysis.
Results:
ARNT2 was upregulated and possessed an excellent discriminatory capability in NPC samples. ARNT2 positively correlated target genes were clustered in pathways in cancer, while negatively correlated target genes were enriched in immune-related pathway. The ChIP-seq information of ARNT2 and histone showed that prostaglandin-endoperoxide synthase 2 (PTGS2) was a potential target gene of ARNT2. CIBERSORTx revealed the immunity status in NPC, and ARNT2 expression was correlated with infiltration of five immune cells.
Conclusions:
ARNT2 is overexpressed in NPC and may regulate PTGS2 to participate in the cancer process. ARNT2 serves as a key oncogenic target in NPC patients.
Insights
Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) is overexpressed in nasopharyngeal carcinoma (NPC), suggesting it may be a key therapeutic target. This study explored ARNT2
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Nasopharyngeal carcinoma (NPC) therapy benefits are limited, necessitating novel therapeutic targets.
- Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) role in NPC is underexplored despite its study in other cancers.
Purpose of the Study:
- To investigate the expression level of ARNT2 in NPC.
- To elucidate the underlying mechanisms of ARNT2 in NPC pathogenesis.
Main Methods:
- Analysis of ARNT2 mRNA expression from public datasets.
- Functional enrichment analysis of ARNT2-coexpressed and target genes.
- ChIP-seq data analysis to identify ARNT2 regulatory targets.
- Immune infiltration assessment using CIBERSORTx and correlation with ARNT2 expression.
Main Results:
- ARNT2 is significantly upregulated in NPC with strong discriminatory power.
- ARNT2 positively correlated genes are involved in cancer pathways; negatively correlated genes in immune pathways.
- Prostaglandin-endoperoxide synthase 2 (PTGS2) identified as a potential ARNT2 target gene.
- ARNT2 expression correlates with the infiltration of five immune cell types in NPC.
Conclusions:
- ARNT2 overexpression in NPC may drive cancer progression, potentially via PTGS2 regulation.
- ARNT2 represents a promising oncogenic target for NPC treatment.
More Related Videos
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
Co-activators and Co-repressors
Directionality of Nuclear Transport
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

